Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis
We aimed to provide insights on the role of the circadian time of administration in influencing the efficacy and tolerability/safety profile of OnabotulinumtoxinA (BoNTA) for chronic migraine (CM) prophylaxis. Methods: We retrospectively reviewed the medical files of BoNTA-naïve patients with CM who...
Main Authors: | Emmanouil V. Dermitzakis, Michail Vikelis, George S. Vlachos, Andreas A. Argyriou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/5/296 |
Similar Items
-
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
by: Michail Vikelis, et al.
Published: (2018-09-01) -
Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic Migraine
by: Emmanouil V. Dermitzakis, et al.
Published: (2022-06-01) -
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine
by: Andreas A. Argyriou, et al.
Published: (2022-12-01) -
Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine
by: Andreas A. Argyriou, et al.
Published: (2024-02-01) -
OnabotulinumtoxinA: Still the Present for Chronic Migraine
by: Carlo Baraldi, et al.
Published: (2023-01-01)